Discounted Cash Flow (DCF) Analysis Unlevered

Sanara MedTech Inc. (SMTI)

$ 28.55
+0.14 (+0.49%)
Stock DCF: -28.21 | 28.55 | overvalue

Operating Data

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 5.516.305.8411.7715.5921.0828.5238.5852.1970.60
Revenue (%)
EBITDA -0.210.22-0.41-2.51-4.71-2.48-3.35-4.54-6.14-8.30
EBITDA (%)
EBIT -0.270.14-0.49-2.63-5-2.76-3.74-5.06-6.84-9.25
EBIT (%)
Depreciation 0.060.080.080.120.290.280.380.520.700.95
Depreciation (%)

Balance Sheet Data

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 0.830.460.736.611.564.275.777.8110.5614.29
Total Cash (%)
Account Receivables 0.790.840.211.342.272.413.274.425.988.09
Account Receivables (%)
Inventories 0.350.710.511.041.371.862.513.404.606.22
Inventories (%)
Accounts Payable 0.240.290.120.410.490.7411.351.832.47
Accounts Payable (%)
Capital Expenditure -0-0.09-0.01-1.71-1.64-1.12-1.52-2.05-2.78-3.76
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 28.55
Beta 2.218
Diluted Shares Outstanding 5.73
Cost of Debt
Tax Rate 2.00
After-tax Cost of Debt 2.34%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.899
Total Debt 0.48
Total Equity 163.72
Total Capital 164.20
Debt Weighting 0.29
Equity Weighting 99.71
Wacc

Build Up Free Cash

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 5.516.305.8411.7715.5921.0828.5238.5852.1970.60
EBITDA -0.210.22-0.41-2.51-4.71-2.48-3.35-4.54-6.14-8.30
EBIT -0.270.14-0.49-2.63-5-2.76-3.74-5.06-6.84-9.25
Tax Rate 0.00%0.00%0.00%0.76%2.00%0.55%0.55%0.55%0.55%0.55%
EBIAT -0.270.14-0.49-2.61-4.90-2.75-3.72-5.03-6.80-9.20
Depreciation 0.060.080.080.120.290.280.380.520.700.95
Accounts Receivable --0.040.62-1.12-0.93-0.15-0.85-1.15-1.56-2.11
Inventories --0.360.20-0.52-0.34-0.48-0.65-0.89-1.20-1.62
Accounts Payable -0.05-0.170.290.090.240.260.350.480.64
Capital Expenditure -0-0.09-0.01-1.71-1.64-1.12-1.52-2.05-2.78-3.76
UFCF -0.21-0.220.24-5.55-7.44-3.98-6.10-8.25-11.16-15.09
WACC
PV UFCF -3.55-4.87-5.89-7.12-8.61
SUM PV UFCF -30.06

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 11.87
Free cash flow (t + 1) -15.85
Terminal Value -230.70
Present Value of Terminal Value -131.67

Intrinsic Value

Enterprise Value -161.73
Net Debt 0.03
Equity Value -161.75
Shares Outstanding 5.73
Equity Value Per Share -28.21